Marhya Júlia Silva Leite

Ms. Marhya Júlia Silva Leite

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2023 in Experimental Biology and Medicine
Verified
Journal Article
Open access
VGVitor Gayger Gayger-Dias
Vitor Gayger Gayger-Dias
AVAdriana Fk Vizuete
Adriana Fk Vizuete
LRLetícia Rodrigues
Letícia Rodrigues
KWKrista Mineia Wartchow
Krista Mineia Wartchow
LBLarissa Daniele Bobermin
Larissa Daniele Bobermin
Carlos-Alberto GonçalvesCarlos-Alberto Gonçalves
Carlos-Alberto Gonçalves
S100B is a 21-kDa protein that is produced and secreted by astrocytes and widely used as a marker of brain injury in clinical and experimental studies. The majority of these studies are based on measurements in blood serum, assuming an associated increase in cerebrospinal fluid and a rupture of the blood–brain barrier (BBB). Moreover, extracerebral sources of S100B are often underestimated. Herein, we will review these interpretations and discuss the routes by which S100B, produced by astrocytes, reaches the circulatory system. We discuss the concept of S100B as an alarmin and its dual activity as an inflammatory and neurotrophic molecule. Furthermore, we emphasize the lack of data supporting the idea that S100B acts as a marker of BBB rupture, and the need to include the glymphatic system in the interpretations of serum changes of S100B. The review is also dedicated to valorizing extracerebral sources of S100B, particularly adipocytes. Furthermore, S100B per se may have direct and indirect modulating roles in brain barriers: on the tight junctions that regulate paracellular transport; on the expression of its receptor, RAGE, which is involved in transcellular protein transport; and on aquaporin-4, a key protein in the glymphatic system that is responsible for the clearance of extracellular proteins from the central nervous system. We hope that the data on S100B, discussed here, will be useful and that it will translate into further health benefits in medical practice.

1 July 2009 in Neuroscience Research
Verified
Journal Article
Open access
LRLetícia Carina Ribeiro
Letícia Carina Ribeiro
AQAndré Quincozes-Santos
André Quincozes-Santos
Marhya Júlia Silva LeiteMarhya Júlia Silva Leite
Marhya Júlia Silva Leite
RARenata Torres Abib
Renata Torres Abib
JKJuliana Kleinkauf-Rocha
Juliana Kleinkauf-Rocha
CGCARMEM GOTTFRIED
CARMEM GOTTFRIED
Recent studies indicate that caloric restriction (CR) protects the central nervous system from several pathological conditions. The impairment of astroglial cell function, including glutamate uptake, glutamine synthetase (GS) activity and S100B secretion, may contribute to the progression of neurological disorders. The present study aimed to evaluate hippocampal astrocytic changes in response to CR diet, measuring astroglial parameters, such as glutamate uptake, GS activity and the immunocontent of GFAP and S100B. Blood biochemical parameters were also analyzed. Rats (60-day old) were fed ad libitum or on CR diets for 12 weeks. CR-fed rats showed approximately 16% less body weight gain than control rats. The CR diet was able to induce a significant increase in glutamate uptake (23%) and in GS activity (26%). There were no statistically significant differences in the immunocontent of either GFAP or S100B. In summary, the present study indicates that CR also modulates astrocyte functions by increasing glutamate uptake and GS activity, suggesting that CR might exert its neuroprotective effects against brain illness by modulation of astrocytic functions.

1 January 2015 in Neural Plasticity
Verified
Journal Article
Open access
PDF file
CBCristiane Batassini
Cristiane Batassini
NBNúbia Broetto
Núbia Broetto
LTLucas Silva Tortorelli
Lucas Silva Tortorelli
MBMilene Borsoi
Milene Borsoi
CZCaroline Zanotto
Caroline Zanotto
Carlos-Alberto GonçalvesCarlos-Alberto Gonçalves
Carlos-Alberto Gonçalves
Both glial fibrillary acidic protein (GFAP) and S100B have been used as markers of astroglial plasticity, particularly in brain injury; however, they do not necessarily change in the same time frame or direction. Herein, we induced a Parkinson’s disease (PD) model via a 6-OHDA intrastriatal injection in rats and investigated the changes in GFAP and S100B using ELISA in the substantia nigra (SN), striatum, and cerebrospinal fluid on the 1st, 7th, and 21st days following the injection. The model was validated using measurements of rotational behaviour induced by methylphenidate and tyrosine hydroxylase in the dopaminergic pathway. To our knowledge, this is the first measurement of cerebrospinal fluid S100B and GFAP in the 6-OHDA model of PD. Gliosis (based on a GFAP increase) was identified in the striatum, but not in the SN. We identified a transitory increment of cerebrospinal fluid S100B and GFAP on the 1st and 7th days, respectively. This initial change in cerebrospinal fluid S100B was apparently related to the mechanical lesion. However, the 6-OHDA-induced S100B secretion was confirmed in astrocyte cultures. Current data reinforce the idea that glial changes precede neuronal damage in PD; however, these findings also indicate that caution is necessary regarding the interpretation of data in this PD model.

1 August 2004 in Brain Research Bulletin
Verified
Journal Article
Closed access
Marhya Júlia Silva LeiteMarhya Júlia Silva Leite
Marhya Júlia Silva Leite
JFJuliana K. Frizzo
Juliana K. Frizzo
PNPatrícia Nardin
Patrícia Nardin
LALúcia Maria Vieira de Almeida
Lúcia Maria Vieira de Almeida
FTFrancine Tramontina
Francine Tramontina
CGCarlos-Alberto Gonçalves
Carlos-Alberto Gonçalves

1 August 2005 in Nutritional Neuroscience
Verified
Journal Article
Closed access
MSM. C. Silva
M. C. Silva
João RochaJoão Rocha
João Rocha
CPC. S. Pires
C. S. Pires
LRL. C. Ribeiro
L. C. Ribeiro
GBG. Brolese
G. Brolese
CGC. A. Gonçalves
C. A. Gonçalves
The ketogenic diet (KD) is a high-fat, low-protein and low-carbohydrate diet included as medical practice against seizure disorders, particularly in children refractory to conventional anti-epileptic drug treatment. However, the molecular basis of its therapeutic effect remains unclear. Considering the growing evidence for the importance of glial cells for neuronal development, survival and plasticity, we investigated astrocyte protein markers from KD fed rats, in different regions of hippocampus, a brain structure commonly involved in seizure disorders. We found a transitory increment in GFAP in the CA3 hippocampal region, but not in the CA1 or dentate gyrus (DG). This change was not accompanied by changes in S100B content or glutamine synthetase activity. In order to evaluate possible hippocampal involvement we investigated spatial-cognitive behavior using the water-maze task. No changes were observed. This transitory gliosis in CA3 could be related to, or precede, other associated changes proposed to be involved in the attenuation of seizure disorders. These data reinforce the importance of hippocampal astrocytes as cell targets during KD feeding.

1 June 2006 in Brain Research Bulletin
Verified
Journal Article
Closed access
Marhya Júlia Silva LeiteMarhya Júlia Silva Leite
Marhya Júlia Silva Leite
GBGiovana Brolese
Giovana Brolese
LALucia Maria Vieira de Almeida
Lucia Maria Vieira de Almeida
CPCristopher Celintano Piñero
Cristopher Celintano Piñero
CGCARMEM GOTTFRIED
CARMEM GOTTFRIED
CGCarlos-Alberto Gonçalves
Carlos-Alberto Gonçalves